About BioImagene
BioImagene is a company based in Sunnyvale (United States) founded in 2003 was acquired by Roche in August 2010. BioImagene has raised $40.2 million across 5 funding rounds from investors including Roche, Burrill and Company and Next47. The company has 40 employees as of December 31, 2009. BioImagene has completed 1 acquisition, including Tissue Informatic. BioImagene operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Sunnyvale, United States
- Employees 40 as on 31 Dec, 2009
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioimagene Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BioImagene
Unlock access to complete
Unlock access to complete
Leadership Team
62 people
Software Development Team
54 people
Human Resources and Administration
40 people
Finance and Accounting
37 people
Operations Team
36 people
Product Management Team
31 people
Sales and Marketing
22 people
Senior Team
19 people
Unlock access to complete
Funding Insights of BioImagene
BioImagene has successfully raised a total of $40.2M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioImagene
BioImagene has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche, Burrill and Company and Next47.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture investments in systems, infrastructure, and applications for enterprise founders.
|
Locked | Locked | Locked | |
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in technology and healthcare sectors.
|
Locked | Locked | Locked |
Investor details for BioImagene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioImagene
BioImagene has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Tissue Informatic.
Investment portfolio details for BioImagene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Tissue imaging systems are developed for biotechnology quantitative analysis.
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for BioImagene
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BioImagene
Detailed financials for BioImagene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioimagene Comparisons
Peer comparison for BioImagene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioImagene
BioImagene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
Detailed competitors of BioImagene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioimagene
Complete news archive for BioImagene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioImagene
BioImagene was founded in 2003.
BioImagene is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
BioImagene is a funded company, having raised a total of $40.2M across 5 funding rounds to date.
As of Dec 31, 2009, the latest employee count at BioImagene is 40.
BioImagene was founded in 2003 and is based in Sunnyvale, United States, within the digital pathology sector. IHC algorithms are provided for cancers including breast (HER2, ERPR, p53, Ki67), brain and prostate (Ki67), multiple myeloma (CD138), and lymphoma (CD3CD20). The iSlide input device is offered for microscope-based manipulation of digital slide images, while iScan Coreo Au scanners support applications such as image analysis, telepathology, remote microscopy, and education.
BioImagene's top competitors include Guardant Health, Foundation Medicine and Natera.
BioImagene has made 1 acquisition, including Tissue Informatic.
BioImagene has 10 investors. Key investors include Roche, Burrill and Company, Next47, Ascension Ventures, and National Healthcare Services.